ADALIMUMAB-ATTO

ADALIMUMAB-ATTO was reported 1610 times

ADALIMUMAB-ATTO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MAGNETIC RESONANCE IMAGING THORACIC ABNORMAL 6 0.3333
1 TRACHEOBRONCHITIS BACTERIAL 5 0.1923
2 THYROID ATROPHY 6 0.0638
3 BASAL CELL CARCINOMA METASTATIC 1 0.0588
4 RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE 4 0.0471
5 SUPERIOR SEMICIRCULAR CANAL DEHISCENCE 1 0.0435
6 WHITE BLOOD CELLS STOOL POSITIVE 1 0.0256
7 ORTHOSTATIC TREMOR 1 0.0238
8 GENITAL HERPES SIMPLEX 5 0.0236
9 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 1 0.0182
10 ANEURYSM REPAIR 2 0.0175
11 NEUROMUSCULAR PAIN 1 0.0172
12 BACTERIAL TRACHEITIS 1 0.0123
13 ANIMAL ATTACK 1 0.0115
14 INTERCEPTED PRODUCT ADMINISTRATION ERROR 75 0.0098
15 URTICARIA CHRONIC 5 0.0089
16 PERIPHERAL NERVE PALSY 1 0.0088
17 BRONCHIAL WALL THICKENING 6 0.0083
18 PERIPORTAL OEDEMA 1 0.0080
19 PORTAL TRACT INFLAMMATION 1 0.0079
20 BRONCHITIS BACTERIAL 6 0.0079
21 TRACHEOBRONCHITIS 6 0.0078
22 PRODUCT COMMUNICATION ISSUE 68 0.0077
23 HILAR LYMPHADENOPATHY 6 0.0068
24 PERINEAL INJURY 1 0.0066
25 HAEMOPHILUS INFECTION 6 0.0061
26 SOCIOECONOMIC PRECARITY 1 0.0058
27 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 194 0.0057
28 DEVICE DIFFICULT TO USE 379 0.0057
29 SICCA SYNDROME 1 0.0052
30 MUCOSAL HAEMORRHAGE 6 0.0052
31 CORTISOL ABNORMAL 1 0.0050
32 DRUG SPECIFIC ANTIBODY ABSENT 1 0.0049
33 CYSTITIS NONINFECTIVE 6 0.0045
34 BRONCHIAL OBSTRUCTION 6 0.0043
35 DRAINAGE 2 0.0041
36 CONJUNCTIVITIS ALLERGIC 6 0.0040
37 VIBRATORY SENSE INCREASED 1 0.0039
38 PRODUCT KNOWLEDGE DEFICIT 3 0.0038
39 GROWTH DISORDER 1 0.0037
40 AGITATED DEPRESSION 1 0.0035
41 INCORRECT DISPOSAL OF PRODUCT 11 0.0034
42 PRODUCT STORAGE ERROR 280 0.0032
43 DRUG DOSE OMISSION BY DEVICE 247 0.0032
44 TRAUMATIC LUNG INJURY 6 0.0031
45 OSTEOTOMY 1 0.0031
46 HEMIPLEGIC MIGRAINE 1 0.0029
47 STIFF PERSON SYNDROME 1 0.0029
48 HEMIHYPOAESTHESIA 1 0.0028
49 TINEA VERSICOLOUR 1 0.0028
50 INJECTION SITE INDENTATION 6 0.0028
51 MILIA 1 0.0028
52 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
53 INJECTION SITE PUSTULE 1 0.0026
54 ARACHNOID CYST 1 0.0025
55 BLOOD IMMUNOGLOBULIN E INCREASED 6 0.0025
56 PRODUCT SUBSTITUTION 1 0.0025
57 ATRIAL TACHYCARDIA 5 0.0024
58 EXPOSURE VIA EYE CONTACT 1 0.0024
59 INFECTED BITE 2 0.0024
60 INTERCEPTED PRODUCT STORAGE ERROR 8 0.0022
61 AORTIC ARTERIOSCLEROSIS 5 0.0019
62 ENTHESOPATHY 3 0.0019
63 C-REACTIVE PROTEIN ABNORMAL 12 0.0019
64 COLONOSCOPY 4 0.0018
65 BONE FRAGMENTATION 1 0.0018
66 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 4 0.0017
67 VERTIGO POSITIONAL 3 0.0017
68 VULVAL CANCER 1 0.0017
69 BRONCHIECTASIS 11 0.0016
70 POST PROCEDURAL INFLAMMATION 1 0.0016
71 CHRONIC SINUSITIS 6 0.0016
72 ACCIDENTAL EXPOSURE TO PRODUCT 164 0.0016
73 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
74 PERIORAL DERMATITIS 1 0.0016
75 GINGIVAL DISCOMFORT 1 0.0015
76 LIP EXFOLIATION 2 0.0015
77 POST PROCEDURAL SEPSIS 1 0.0015
78 HEPATIC CYST 5 0.0015
79 NEUROENDOCRINE CARCINOMA 1 0.0014
80 BRONCHIOLITIS 5 0.0014
81 INJURY ASSOCIATED WITH DEVICE 28 0.0014
82 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
83 SMALL CELL LUNG CANCER 2 0.0013
84 AUTOIMMUNE THYROIDITIS 5 0.0013
85 SQUAMOUS CELL CARCINOMA OF LUNG 1 0.0013
86 VEIN COLLAPSE 1 0.0013
87 GENITAL ULCERATION 1 0.0013
88 MYCOPLASMA INFECTION 1 0.0013
89 PRODUCT CONFUSION 1 0.0013
90 OCCUPATIONAL EXPOSURE TO PRODUCT 8 0.0012
91 EXPOSURE VIA SKIN CONTACT 32 0.0012
92 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
93 BREATH SOUNDS ABNORMAL 6 0.0012
94 GIANT CELL ARTERITIS 1 0.0012
95 INCREASED UPPER AIRWAY SECRETION 6 0.0012
96 CRANIOFACIAL FRACTURE 1 0.0012
97 ABSCESS DRAINAGE 1 0.0012
98 INCORRECT DOSE ADMINISTERED BY DEVICE 30 0.0011
99 BLOOD CREATINE INCREASED 5 0.0011
100 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
101 LIGAMENT DISORDER 1 0.0011
102 DEVICE USE ERROR 38 0.0011
103 SKIN GRAFT 1 0.0011
104 INJECTION SITE CELLULITIS 2 0.0011
105 ARNOLD-CHIARI MALFORMATION 1 0.0010
106 CORRECTIVE LENS USER 1 0.0010
107 MASTOIDITIS 1 0.0010
108 DILATED CARDIOMYOPATHY 1 0.0010
109 FEAR OF INJECTION 7 0.0010
110 INJECTION SITE HYPERSENSITIVITY 3 0.0010
111 PANCREATIC MASS 1 0.0009
112 FOETAL MALFORMATION 1 0.0009
113 ONYCHOMYCOSIS 4 0.0009
114 ADVERSE REACTION 12 0.0009
115 RHEUMATOID FACTOR POSITIVE 5 0.0009
116 OSTEOCHONDROSIS 1 0.0009
117 VITILIGO 2 0.0009
118 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 2 0.0008
119 ENCEPHALITIS VIRAL 1 0.0008
120 JUVENILE IDIOPATHIC ARTHRITIS 2 0.0008
121 AORTIC VALVE REPLACEMENT 1 0.0008
122 LUPUS VULGARIS 1 0.0008
123 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
124 FISTULA DISCHARGE 1 0.0008
125 ABDOMINAL OPERATION 1 0.0008
126 PULMONARY HAEMORRHAGE 6 0.0008
127 POSTPARTUM HAEMORRHAGE 1 0.0007
128 PERIPHERAL VENOUS DISEASE 3 0.0007
129 DRUG SPECIFIC ANTIBODY 1 0.0007
130 INJECTION SITE INJURY 4 0.0007
131 ONYCHOMADESIS 3 0.0007
132 HAND FRACTURE 5 0.0007
133 PRODUCT ADMINISTRATION ERROR 14 0.0007
134 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
135 MUTISM 1 0.0007
136 CARDIAC FIBRILLATION 1 0.0007
137 RHEUMATIC FEVER 3 0.0007
138 GASTROINTESTINAL WALL THICKENING 1 0.0007
139 HYPOSMIA 1 0.0007
140 VASCULAR RUPTURE 1 0.0006
141 FAECAL CALPROTECTIN INCREASED 2 0.0006
142 NASAL ULCER 1 0.0006
143 SCLERITIS 1 0.0006
144 FACET JOINT SYNDROME 2 0.0006
145 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
146 SHOULDER FRACTURE 1 0.0006
147 INJECTION RELATED REACTION 1 0.0006
148 INFLAMMATORY MARKER INCREASED 3 0.0006
149 BLOOD CALCIUM ABNORMAL 1 0.0006
150 LIVE BIRTH 5 0.0006
151 SKIN WOUND 1 0.0006
152 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
153 AMYLOIDOSIS 1 0.0006
154 MUSCLE STRAIN 5 0.0006
155 BREAST CYST 1 0.0006
156 CARDIAC ABLATION 1 0.0006
157 X-RAY ABNORMAL 1 0.0006
158 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
159 HIDRADENITIS 5 0.0005
160 UROSEPSIS 5 0.0005
161 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
162 PRODUCT PREPARATION ERROR 11 0.0005
163 LIP DISORDER 1 0.0005
164 PRODUCT STORAGE ISSUE 2 0.0005
165 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
166 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
167 VOCAL CORD DISORDER 1 0.0005
168 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
169 EAR HAEMORRHAGE 1 0.0005
170 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
171 THERAPY INTERRUPTED 35 0.0005
172 DERMATITIS PSORIASIFORM 1 0.0005
173 INJECTION SITE URTICARIA 12 0.0005
174 SPINAL COMPRESSION FRACTURE 4 0.0005
175 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
176 LATENT TUBERCULOSIS 1 0.0005
177 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
178 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
179 IMMUNODEFICIENCY 7 0.0005
180 PULMONARY FIBROSIS 9 0.0005
181 PRODUCT DISPENSING ISSUE 2 0.0005
182 HIATUS HERNIA 6 0.0005
183 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
184 RHEUMATOID ARTHRITIS 51 0.0004
185 OSTEOMYELITIS 8 0.0004
186 LUPUS-LIKE SYNDROME 4 0.0004
187 DISLOCATION OF VERTEBRA 1 0.0004
188 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87 0.0004
189 FEELING OF DESPAIR 2 0.0004
190 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3 0.0004
191 HYPERTHYROIDISM 6 0.0004
192 FINGER DEFORMITY 2 0.0004
193 COELIAC DISEASE 4 0.0004
194 INJECTION SITE PAIN 125 0.0004
195 CEREBRAL DISORDER 3 0.0004
196 FOOT OPERATION 2 0.0004
197 INJECTION SITE HAEMORRHAGE 32 0.0004
198 ERYSIPELAS 2 0.0004
199 DRUG TOLERANCE 2 0.0004
200 LIPOMA 1 0.0004
201 NASAL DISORDER 1 0.0004
202 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
203 ANAL FISTULA 2 0.0004
204 PSORIATIC ARTHROPATHY 15 0.0004
205 HIP SURGERY 2 0.0004
206 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
207 CLUMSINESS 1 0.0004
208 ULCERATIVE KERATITIS 1 0.0004
209 NONSPECIFIC REACTION 2 0.0004
210 MACULE 1 0.0004
211 INJECTION SITE RASH 11 0.0004
212 PROCTITIS 1 0.0004
213 MACULAR OEDEMA 2 0.0004
214 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
215 DRUG TOLERANCE DECREASED 1 0.0004
216 INJECTION SITE SCAR 1 0.0004
217 PRODUCT LABEL CONFUSION 2 0.0003
218 GASTROINTESTINAL NECROSIS 1 0.0003
219 NAIL DISORDER 3 0.0003
220 GRIP STRENGTH DECREASED 3 0.0003
221 TOOTH DISCOLOURATION 1 0.0003
222 INFUSION SITE REACTION 1 0.0003
223 ATYPICAL PNEUMONIA 1 0.0003
224 SYNOVITIS 6 0.0003
225 INJECTION SITE VESICLES 2 0.0003
226 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
227 OSTEOPENIA 5 0.0003
228 EYE INJURY 1 0.0003
229 INJECTION SITE REACTION 22 0.0003
230 BRAIN FOG 5 0.0003
231 BLEPHAROSPASM 2 0.0003
232 HEPATITIS B REACTIVATION 1 0.0003
233 BLADDER PAIN 1 0.0003
234 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
235 SWOLLEN JOINT COUNT INCREASED 1 0.0003
236 INJECTION SITE BRUISING 25 0.0003
237 PROCTALGIA 2 0.0003
238 BREAST CANCER STAGE III 2 0.0003
239 AUTOIMMUNE DISORDER 3 0.0003
240 THERAPY CHANGE 3 0.0003
241 PRODUCT PREPARATION ISSUE 2 0.0003
242 NEAR DEATH EXPERIENCE 1 0.0003
243 SARS-COV-2 TEST POSITIVE 4 0.0003
244 OTITIS MEDIA 1 0.0003
245 BLADDER DISORDER 3 0.0003
246 LYME DISEASE 1 0.0003
247 ANXIETY DISORDER 1 0.0003
248 PLANTAR FASCIITIS 1 0.0003
249 POSTOPERATIVE WOUND INFECTION 2 0.0003
250 ULCER HAEMORRHAGE 2 0.0003
251 PUSTULAR PSORIASIS 1 0.0003
252 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
253 JOINT EFFUSION 2 0.0003
254 CERVICAL VERTEBRAL FRACTURE 1 0.0003
255 FOLLICULITIS 3 0.0003
256 BONE EROSION 1 0.0003
257 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
258 PYODERMA GANGRENOSUM 1 0.0003
259 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
260 FOOD INTOLERANCE 1 0.0003
261 THROMBOCYTOSIS 1 0.0003
262 RECTAL DISCHARGE 1 0.0003
263 INFLAMMATION 14 0.0003
264 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
265 NERVE INJURY 3 0.0003
266 DUODENAL ULCER PERFORATION 2 0.0003
267 RESPIRATORY TRACT INFECTION 7 0.0003
268 TREATMENT FAILURE 22 0.0003
269 CHEMOTHERAPY 1 0.0003
270 FOOT FRACTURE 5 0.0003
271 GASTRIC INFECTION 1 0.0003
272 OESOPHAGEAL DISORDER 1 0.0003
273 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
274 DISABILITY 5 0.0003
275 SPINAL FUSION SURGERY 1 0.0002
276 POST PROCEDURAL INFECTION 2 0.0002
277 INTENTIONAL DOSE OMISSION 7 0.0002
278 POLYURIA 2 0.0002
279 SPINAL OPERATION 3 0.0002
280 STAPHYLOCOCCAL INFECTION 8 0.0002
281 MUSCLE INJURY 2 0.0002
282 INJECTION SITE DISCOLOURATION 3 0.0002
283 PEMPHIGUS 3 0.0002
284 THROAT CANCER 1 0.0002
285 HEPATITIS 6 0.0002
286 SHOULDER OPERATION 1 0.0002
287 CHAPPED LIPS 1 0.0002
288 HAND DEFORMITY 3 0.0002
289 DIVERTICULUM INTESTINAL 1 0.0002
290 IMMUNE SYSTEM DISORDER 3 0.0002
291 ANKYLOSING SPONDYLITIS 3 0.0002
292 JOINT RANGE OF MOTION DECREASED 3 0.0002
293 LIP DRY 2 0.0002
294 URINE ABNORMALITY 1 0.0002
295 EXOSTOSIS 2 0.0002
296 DISEASE COMPLICATION 1 0.0002
297 EAR DISORDER 1 0.0002
298 EYE OPERATION 1 0.0002
299 CHRONIC MYELOID LEUKAEMIA 1 0.0002
300 HAEMOPTYSIS 6 0.0002
301 THERAPY CESSATION 11 0.0002
302 SLEEP DISORDER 15 0.0002
303 MUSCULOSKELETAL DISORDER 4 0.0002
304 GAIT INABILITY 7 0.0002
305 LIMB OPERATION 1 0.0002
306 HYPERCHOLESTEROLAEMIA 2 0.0002
307 GUILLAIN-BARRE SYNDROME 1 0.0002
308 ORAL HERPES 4 0.0002
309 INFLAMMATORY BOWEL DISEASE 2 0.0002
310 PHARYNGEAL SWELLING 2 0.0002
311 RENAL CELL CARCINOMA 1 0.0002
312 NASAL POLYPS 1 0.0002
313 ABDOMINAL TENDERNESS 1 0.0002
314 HEPATIC ENZYME ABNORMAL 1 0.0002
315 HELICOBACTER INFECTION 2 0.0002
316 TRISMUS 1 0.0002
317 SENSITIVITY TO WEATHER CHANGE 1 0.0002
318 KNEE ARTHROPLASTY 4 0.0002
319 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
320 COMPRESSION FRACTURE 1 0.0002
321 INTESTINAL RESECTION 1 0.0002
322 ANAL ABSCESS 1 0.0002
323 PHARYNGITIS STREPTOCOCCAL 2 0.0002
324 BACK INJURY 2 0.0002
325 LUNG DISORDER 9 0.0002
326 HYDROCEPHALUS 1 0.0002
327 WOUND INFECTION 2 0.0002
328 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
329 INTERMENSTRUAL BLEEDING 1 0.0002
330 PERICARDITIS 3 0.0002
331 SKIN INFECTION 2 0.0002
332 PRODUCT LEAKAGE 1 0.0002
333 FISTULA 2 0.0002
334 HEPATIC ENZYME INCREASED 12 0.0002
335 PERONEAL NERVE PALSY 1 0.0002
336 GASTRIC DISORDER 6 0.0002
337 JOINT SWELLING 21 0.0002
338 HERPES VIRUS INFECTION 1 0.0002
339 VASCULITIS 2 0.0002
340 SPINAL PAIN 2 0.0002
341 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
342 INJECTION SITE SWELLING 13 0.0002
343 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
344 CATARACT OPERATION 1 0.0002
345 SYMPTOM RECURRENCE 1 0.0002
346 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
347 C-REACTIVE PROTEIN INCREASED 6 0.0002
348 BURSITIS 2 0.0002
349 SCOLIOSIS 1 0.0002
350 INFUSION SITE EXTRAVASATION 1 0.0002
351 BRAIN OEDEMA 2 0.0002
352 PHOTOPSIA 1 0.0002
353 THERAPEUTIC RESPONSE CHANGED 1 0.0002
354 PULMONARY OEDEMA 7 0.0002
355 THERAPY NON-RESPONDER 7 0.0002
356 DRUG INTOLERANCE 15 0.0002
357 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
358 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
359 PLATELET COUNT INCREASED 2 0.0002
360 DYSPEPSIA 15 0.0002
361 WALKING AID USER 1 0.0002
362 SKIN DISORDER 5 0.0001
363 PREGNANCY 3 0.0001
364 SKIN MASS 1 0.0001
365 INJECTION SITE PRURITUS 10 0.0001
366 MUSCULOSKELETAL STIFFNESS 13 0.0001
367 TASTE DISORDER 3 0.0001
368 VERTIGO 9 0.0001
369 UVEITIS 2 0.0001
370 PRODUCT LABEL ISSUE 1 0.0001
371 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
372 INJECTION SITE WARMTH 3 0.0001
373 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
374 ADVERSE DRUG REACTION 13 0.0001
375 LYMPHOEDEMA 1 0.0001
376 ARTHROPATHY 8 0.0001
377 ABDOMINAL DISTENSION 15 0.0001
378 WOUND 4 0.0001
379 DEFAECATION URGENCY 1 0.0001
380 SEASONAL ALLERGY 2 0.0001
381 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
382 ARTHRITIS 11 0.0001
383 LIVER FUNCTION TEST INCREASED 3 0.0001
384 IMPAIRED QUALITY OF LIFE 2 0.0001
385 PRODUCT DISPENSING ERROR 3 0.0001
386 FAECES SOFT 1 0.0001
387 ORAL DISORDER 1 0.0001
388 ARTHROPOD BITE 1 0.0001
389 COLITIS ULCERATIVE 6 0.0001
390 SUNBURN 1 0.0001
391 GLOSSODYNIA 3 0.0001
392 GENERAL SYMPTOM 1 0.0001
393 PEMPHIGOID 1 0.0001
394 ILL-DEFINED DISORDER 8 0.0001
395 INSURANCE ISSUE 2 0.0001
396 HIP ARTHROPLASTY 2 0.0001
397 PSORIASIS 17 0.0001
398 CONGENITAL ANOMALY 1 0.0001
399 HYPOALBUMINAEMIA 1 0.0001
400 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
401 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
402 FURUNCLE 1 0.0001
403 OBESITY 2 0.0001
404 ABSCESS 2 0.0001
405 SENSORY LOSS 1 0.0001
406 NIGHT SWEATS 4 0.0001
407 STENT PLACEMENT 1 0.0001
408 MYASTHENIA GRAVIS 1 0.0001
409 FRUSTRATION TOLERANCE DECREASED 1 0.0001
410 LIVER INJURY 3 0.0001
411 ABNORMAL FAECES 1 0.0001
412 MULTIPLE FRACTURES 2 0.0001
413 HYPERAESTHESIA 1 0.0001
414 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
415 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
416 MENSTRUAL DISORDER 1 0.0001
417 BREAST CANCER STAGE II 1 0.0001
418 URTICARIA 20 0.0001
419 CONDITION AGGRAVATED 36 0.0001
420 SWELLING 11 0.0001
421 FACIAL PARALYSIS 1 0.0001
422 SCAR 2 0.0001
423 ILLNESS 12 0.0001
424 PSYCHOLOGICAL TRAUMA 1 0.0001
425 PAIN 71 0.0001
426 HYSTERECTOMY 1 0.0001
427 MUCOSAL INFLAMMATION 3 0.0001
428 DEVICE USE ISSUE 2 0.0001
429 COLD SWEAT 2 0.0001
430 INJECTION SITE ERYTHEMA 14 0.0001
431 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
432 HEAVY MENSTRUAL BLEEDING 1 0.0001
433 OROPHARYNGEAL DISCOMFORT 1 0.0001
434 OPTIC NEURITIS 1 0.0001
435 SKIN LESION 3 0.0001
436 PNEUMONIA BACTERIAL 1 0.0001
437 DIVERTICULITIS 3 0.0001
438 THINKING ABNORMAL 2 0.0001
439 NEPHROPATHY 1 0.0001
440 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
441 FLANK PAIN 1 0.0001
442 PHOTOPHOBIA 2 0.0001
443 EYE INFLAMMATION 1 0.0001
444 POST PROCEDURAL COMPLICATION 2 0.0001
445 LOWER LIMB FRACTURE 2 0.0001
446 ERUCTATION 2 0.0001
447 HYPERSENSITIVITY 19 0.0001
448 SURGERY 6 0.0001
449 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
450 HEPATOMEGALY 1 0.0001
451 VITREOUS FLOATERS 1 0.0001
452 KNEE OPERATION 1 0.0001
453 LIGAMENT SPRAIN 1 0.0001
454 INABILITY TO AFFORD MEDICATION 1 0.0001
455 BLOOD PRESSURE ABNORMAL 2 0.0001
456 DISCOMFORT 6 0.0001
457 DRUG LEVEL DECREASED 1 0.0001
458 INITIAL INSOMNIA 1 0.0001
459 RIB FRACTURE 2 0.0001
460 ARTHRALGIA 40 0.0001
461 PETECHIAE 1 0.0001
462 NERVOUSNESS 5 0.0001
463 UNINTENDED PREGNANCY 1 0.0001
464 DRUG-INDUCED LIVER INJURY 3 0.0001
465 ECZEMA 5 0.0001
466 JOINT DISLOCATION 1 0.0001
467 BRONCHITIS 7 0.0001
468 OSTEOARTHRITIS 4 0.0001
469 IRRITABLE BOWEL SYNDROME 2 0.0001
470 RECTAL HAEMORRHAGE 4 0.0001
471 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
472 EYE DISORDER 3 0.0001
473 BLOOD PRESSURE DECREASED 6 0.0001
474 NEOPLASM MALIGNANT 6 0.0001
475 MALNUTRITION 1 0.0001
476 EYE PRURITUS 3 0.0001
477 SNEEZING 2 0.0001
478 TYPE 2 DIABETES MELLITUS 3 0.0001
479 BLISTER 5 0.0001
480 IMPAIRED DRIVING ABILITY 1 0.0001
481 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
482 NEOPLASM 1 0.0001
483 PRODUCT SUBSTITUTION ISSUE 5 0.0001
484 RASH MACULAR 3 0.0001
485 MIGRAINE 8 0.0001
486 MACULAR DEGENERATION 1 0.0001
487 HYPERLIPIDAEMIA 1 0.0001
488 LOCALISED INFECTION 2 0.0001
489 FIBROMYALGIA 2 0.0001
490 SMALL INTESTINAL OBSTRUCTION 1 0.0001
491 PNEUMONIA 26 0.0001
492 DIABETES MELLITUS 6 0.0001
493 INJECTION SITE IRRITATION 1 0.0001
494 OFF LABEL USE 68 0.0001
495 INFUSION SITE PAIN 1 0.0001
496 INJECTION SITE INDURATION 1 0.0001
497 DEAFNESS 2 0.0001
498 BEDRIDDEN 1 0.0001
499 ORAL CANDIDIASIS 1 0.0001
500 DYSMENORRHOEA 1 0.0001
501 EYE HAEMORRHAGE 1 0.0001
502 COVID-19 13 0.0001
503 EXTRA DOSE ADMINISTERED 3 0.0001
504 THROAT TIGHTNESS 2 0.0001
505 PERIPHERAL COLDNESS 1 0.0001
506 MEMORY IMPAIRMENT 10 0.0001
507 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
508 FEELING COLD 2 0.0001
509 APHONIA 1 0.0001
510 DEMENTIA 2 0.0001
511 MASS 1 0.0001
512 CARPAL TUNNEL SYNDROME 1 0.0001
513 RASH 31 0.0001
514 SKIN REACTION 1 0.0001
515 BLINDNESS UNILATERAL 1 0.0001
516 HYPERSOMNIA 2 0.0001
517 PARAESTHESIA ORAL 1 0.0001
518 MENTAL DISORDER 3 0.0001
519 INJECTION SITE HAEMATOMA 1 0.0001
520 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
521 DRUG INEFFECTIVE 90 0.0001
522 INSOMNIA 18 0.0001
523 DEHYDRATION 9 0.0001
524 GASTROINTESTINAL DISORDER 6 0.0001
525 RESPIRATORY DISORDER 2 0.0001
526 HYPOAESTHESIA ORAL 1 0.0001
527 UNEVALUABLE EVENT 5 0.0001
528 ECONOMIC PROBLEM 1 0.0001
529 EPILEPSY 2 0.0001
530 ADVERSE EVENT 6 0.0001
531 TENDONITIS 1 0.0001
532 EXPOSURE DURING PREGNANCY 4 0.0001
533 BLOOD CHOLESTEROL INCREASED 3 0.0001
534 THERAPY PARTIAL RESPONDER 1 0.0001
535 SWOLLEN TONGUE 2 0.0001
536 PRODUCT USE ISSUE 12 0.0001
537 ABDOMINAL PAIN UPPER 13 0.0001
538 DISEASE RECURRENCE 3 0.0001
539 RENAL CANCER 3 0.0001
540 MULTIPLE SCLEROSIS 3 0.0001
541 SCIATICA 1 0.0001
542 ASTHMA 7 0.0001
543 MUSCLE TIGHTNESS 1 0.0001
544 IMPAIRED HEALING 2 0.0001
545 INFUSION RELATED REACTION 4 0.0001
546 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
547 LIP SWELLING 2 0.0001
548 ABDOMINAL DISCOMFORT 10 0.0001
549 HOSPITALISATION 9 0.0001
550 PARANOIA 1 0.0001
551 PAIN IN EXTREMITY 17 0.0001
552 SYRINGE ISSUE 1 0.0001
553 HEAD DISCOMFORT 1 0.0001
554 ABDOMINAL PAIN 13 0.0001
555 TOOTHACHE 1 0.0001
556 RESTLESS LEGS SYNDROME 1 0.0001
557 PANIC ATTACK 2 0.0001
558 TREATMENT NONCOMPLIANCE 3 0.0001
559 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
560 HAEMATOCHEZIA 3 0.0001
561 INJECTION SITE MASS 2 0.0001
562 NECK PAIN 3 0.0001
563 BACTERIAL INFECTION 1 0.0001
564 MIDDLE INSOMNIA 1 0.0001
565 OXYGEN SATURATION DECREASED 3 0.0001
566 HEPATIC CIRRHOSIS 1 0.0001
567 INTESTINAL OBSTRUCTION 2 0.0001
568 FRACTURE 1 0.0001
569 MUSCULAR WEAKNESS 6 0.0001
570 COLITIS 2 0.0001
571 MALAISE 23 0.0001
572 BLOOD PRESSURE INCREASED 8 0.0001
573 HERPES ZOSTER 3 0.0001
574 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
575 PRURITUS 20 0.0001
576 CONTUSION 5 0.0001
577 HERNIA 1 0.0001
578 PRESCRIBED OVERDOSE 1 0.0001
579 EAR PAIN 1 0.0001
580 ALOPECIA 10 0.0001
581 PARAESTHESIA 8 0.0001
582 SINUS DISORDER 1 0.0001
583 UPPER LIMB FRACTURE 1 0.0001
584 ABORTION SPONTANEOUS 2 0.0000
585 STOMATITIS 3 0.0000
586 FEEDING DISORDER 1 0.0000
587 PLEURAL EFFUSION 3 0.0000
588 WEIGHT INCREASED 11 0.0000
589 BODY TEMPERATURE INCREASED 1 0.0000
590 FEELING HOT 3 0.0000
591 OSTEOPOROSIS 2 0.0000
592 INFECTION 7 0.0000
593 TOOTH LOSS 1 0.0000
594 POOR QUALITY SLEEP 1 0.0000
595 HEADACHE 29 0.0000
596 AMNESIA 3 0.0000
597 SWELLING FACE 3 0.0000
598 DYSPNOEA 26 0.0000
599 PRODUCT PRESCRIBING ISSUE 1 0.0000
600 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
601 PERIPHERAL SWELLING 7 0.0000
602 LIVER DISORDER 2 0.0000
603 CHROMATURIA 1 0.0000
604 PRODUCT AVAILABILITY ISSUE 1 0.0000
605 NEPHROLITHIASIS 2 0.0000
606 SKIN DISCOLOURATION 2 0.0000
607 RENAL DISORDER 2 0.0000
608 PALPITATIONS 5 0.0000
609 HYPERTENSION 9 0.0000
610 RASH ERYTHEMATOUS 2 0.0000
611 MOBILITY DECREASED 3 0.0000
612 CEREBROVASCULAR ACCIDENT 7 0.0000
613 MENTAL IMPAIRMENT 1 0.0000
614 PRESYNCOPE 1 0.0000
615 NEURALGIA 1 0.0000
616 FATIGUE 32 0.0000
617 VISUAL IMPAIRMENT 5 0.0000
618 HYPOAESTHESIA 6 0.0000
619 CARDIOVASCULAR DISORDER 1 0.0000
620 NAUSEA 31 0.0000
621 HYPOPHAGIA 1 0.0000
622 DRUG RESISTANCE 1 0.0000
623 HYPERHIDROSIS 5 0.0000
624 ANAPHYLACTIC SHOCK 1 0.0000
625 MUSCULOSKELETAL PAIN 2 0.0000
626 JOINT STIFFNESS 1 0.0000
627 DIZZINESS 19 0.0000
628 GASTRITIS 1 0.0000
629 PANCREATITIS 2 0.0000
630 DEPRESSED MOOD 2 0.0000
631 DISTURBANCE IN ATTENTION 2 0.0000
632 FREQUENT BOWEL MOVEMENTS 1 0.0000
633 DRY MOUTH 3 0.0000
634 RASH PRURITIC 2 0.0000
635 LIMB INJURY 1 0.0000
636 PNEUMONITIS 1 0.0000
637 GAIT DISTURBANCE 7 0.0000
638 ANAPHYLACTIC REACTION 2 0.0000
639 PROCEDURAL PAIN 1 0.0000
640 SEPSIS 4 0.0000
641 RENAL IMPAIRMENT 3 0.0000
642 EYE PAIN 2 0.0000
643 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
644 FLATULENCE 2 0.0000
645 BACK PAIN 8 0.0000
646 LIVER FUNCTION TEST ABNORMAL 1 0.0000
647 NEEDLE ISSUE 1 0.0000
648 DYSPHONIA 2 0.0000
649 CHILLS 4 0.0000
650 VOMITING 16 0.0000
651 TACHYCARDIA 3 0.0000
652 WHEEZING 2 0.0000
653 APHASIA 1 0.0000
654 LACRIMATION INCREASED 1 0.0000
655 THERAPEUTIC RESPONSE DECREASED 2 0.0000
656 SUICIDAL IDEATION 3 0.0000
657 MUSCLE SPASMS 6 0.0000
658 ACUTE KIDNEY INJURY 5 0.0000
659 NASOPHARYNGITIS 6 0.0000
660 DIARRHOEA 21 0.0000
661 OROPHARYNGEAL PAIN 3 0.0000
662 LIMB DISCOMFORT 1 0.0000
663 FEMUR FRACTURE 1 0.0000
664 WEIGHT DECREASED 9 0.0000
665 DYSPHAGIA 3 0.0000
666 PULMONARY EMBOLISM 3 0.0000
667 NEUROPATHY PERIPHERAL 3 0.0000
668 MOOD SWINGS 1 0.0000
669 MOVEMENT DISORDER 1 0.0000
670 RHINORRHOEA 2 0.0000
671 DEPRESSION 7 0.0000
672 PRODUCT DOSE OMISSION ISSUE 9 0.0000
673 CHOLELITHIASIS 1 0.0000
674 FUNGAL INFECTION 1 0.0000
675 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
676 SINUSITIS 3 0.0000
677 DELIRIUM 1 0.0000
678 BURNING SENSATION 2 0.0000
679 INJURY 2 0.0000
680 HYPOXIA 1 0.0000
681 LYMPHADENOPATHY 1 0.0000
682 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
683 ANXIETY 8 0.0000
684 CEREBRAL HAEMORRHAGE 1 0.0000
685 UNDERDOSE 2 0.0000
686 AGITATION 2 0.0000
687 DYSURIA 1 0.0000
688 CHEST PAIN 5 0.0000
689 EYE SWELLING 1 0.0000
690 DYSARTHRIA 1 0.0000
691 PYREXIA 9 0.0000
692 CARDIAC FAILURE CONGESTIVE 2 0.0000
693 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
694 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
695 BLINDNESS 1 0.0000
696 TREMOR 4 0.0000
697 URINARY TRACT INFECTION 4 0.0000
698 HYPOACUSIS 1 0.0000
699 VAGINAL HAEMORRHAGE 1 0.0000
700 CONSTIPATION 5 0.0000
701 INTENTIONAL PRODUCT MISUSE 2 0.0000
702 ANGIOEDEMA 1 0.0000
703 DRY SKIN 3 0.0000
704 THROAT IRRITATION 1 0.0000
705 PRODUCT QUALITY ISSUE 3 0.0000
706 INCORRECT DOSE ADMINISTERED 5 0.0000
707 VISION BLURRED 3 0.0000
708 SKIN IRRITATION 1 0.0000
709 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
710 BREAST CANCER 2 0.0000
711 COUGH 6 0.0000
712 CARDIAC DISORDER 2 0.0000
713 OCULAR HYPERAEMIA 1 0.0000
714 ANAEMIA 4 0.0000
715 PRODUCTIVE COUGH 1 0.0000
716 FEELING ABNORMAL 5 0.0000
717 INTERSTITIAL LUNG DISEASE 1 0.0000
718 HEART RATE INCREASED 2 0.0000
719 CELLULITIS 1 0.0000
720 FLUSHING 2 0.0000
721 FLUID RETENTION 1 0.0000
722 ERYTHEMA 4 0.0000
723 SPEECH DISORDER 1 0.0000
724 ASTHENIA 7 0.0000
725 CONFUSIONAL STATE 3 0.0000
726 OEDEMA 1 0.0000
727 MEDICATION ERROR 1 0.0000
728 DEATH 15 0.0000
729 EYE IRRITATION 1 0.0000
730 SEIZURE 2 0.0000
731 BONE PAIN 1 0.0000
732 NASAL CONGESTION 1 0.0000
733 DISEASE PROGRESSION 2 0.0000
734 CATARACT 1 0.0000
735 NO ADVERSE EVENT 3 0.0000
736 EMOTIONAL DISTRESS 2 0.0000
737 OEDEMA PERIPHERAL 2 0.0000
738 LOSS OF CONSCIOUSNESS 2 0.0000
739 DEEP VEIN THROMBOSIS 1 0.0000
740 FALL 5 0.0000
741 HYPOTENSION 3 0.0000
742 SOMNOLENCE 3 0.0000
743 SKIN BURNING SENSATION 1 0.0000
744 RESPIRATORY FAILURE 1 0.0000
745 EPISTAXIS 1 0.0000
746 DECREASED APPETITE 3 0.0000
747 CARDIAC FAILURE 1 0.0000
748 INFLUENZA LIKE ILLNESS 1 0.0000
749 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
750 SKIN EXFOLIATION 1 0.0000
751 BALANCE DISORDER 1 0.0000
752 MYOCARDIAL INFARCTION 2 0.0000
753 ATRIAL FIBRILLATION 1 0.0000
754 CHEST DISCOMFORT 1 0.0000
755 HAEMOGLOBIN DECREASED 1 0.0000
756 OVERDOSE 2 0.0000
757 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
758 INFLUENZA 1 0.0000
759 NEUTROPENIA 1 0.0000
760 DRUG INTERACTION 1 0.0000
761 DRUG DEPENDENCE 1 0.0000